About Gleamer
Gleamer is a company based in Paris (France) founded in 2017 was acquired by RadNet in March 2026. Gleamer has raised $40.01 million across 4 funding rounds from investors including RadNet, EIT Health and Bpifrance. Gleamer has completed 1 acquisition, including Pixyl. Gleamer offers products and services including BoneView, ChestView, BoneMetrics, BoneAge, and BreastView. Gleamer operates in a competitive market with competitors including Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gleamer
Gleamer offers a comprehensive portfolio of products and services, including BoneView, ChestView, BoneMetrics, BoneAge, and BreastView.
Detects bone trauma in X-rays for improved accuracy.
Enhances detection of urgent chest findings and cancers.
Automates musculoskeletal measurements to save time.
Determines bone age beyond traditional methods accurately.
Aids in early detection of breast cancer through precision AI.
People of Gleamer
Unlock access to complete
Unlock access to complete
Funding Insights of Gleamer
Gleamer has successfully raised a total of $40.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $29.55 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gleamer
Gleamer has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include RadNet, EIT Health and Bpifrance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Heal Capital is focused on investing in HealthTech startups.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked |
Investor details for Gleamer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gleamer
Gleamer has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pixyl.
Investment portfolio details for Gleamer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI tools for neuroimage analysis are developed for clinicians.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Gleamer
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Gleamer
Detailed financials for Gleamer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gleamer Comparisons
Peer comparison for Gleamer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gleamer
Gleamer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
Detailed competitors of Gleamer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gleamer
Complete news archive for Gleamer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gleamer
Gleamer was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Gleamer is headquartered in Paris, France.
Gleamer is a funded company, having raised a total of $40.01M across 4 funding rounds to date.
Gleamer was founded in 2017 and is based in Paris, France. Operations center on the healthcare technology sector, where an AI-based platform is developed for medical image interpretation. The flagship Gleamer Copilot integrates multiple AI models to support analysis of X-rays, CT scans, and MRIs. Deep learning algorithms are employed to identify anomalies and produce reports, aiding radiologists in diagnostics and clinical processes.
Gleamer's top competitors include Perspectum, Qure.ai and Deeptek.
Gleamer offers BoneView, ChestView, BoneMetrics, BoneAge, and BreastView.
Gleamer has made 1 acquisition, including Pixyl.
Gleamer has 12 investors. Key investors include RadNet, EIT Health, Bpifrance, Supernova Invest, and Heal Capital.